Company Filing History:
Years Active: 1995-2021
Title: Björn Norrlind: Innovator in Injectable Suspensions
Introduction
Björn Norrlind is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable suspensions. His innovative work focuses on improving the stability and efficacy of drug formulations.
Latest Patents
Björn Norrlind holds a patent for an "Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof." This invention relates to aseptic suspensions that are physically stable and can be injected through a 25G needle or thinner. The formulation includes crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, combined with a mixture of acylglycerols and cholesterol. The patent also outlines processes for preparing these crystalline particles suitable for such suspensions, as well as methods for manufacturing the suspensions themselves.
Career Highlights
Björn Norrlind is associated with Asarina Pharma AB, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in drug delivery systems, enhancing patient care through improved medication administration.
Collaborations
Throughout his career, Björn has collaborated with talented professionals, including Magnus Brisander and Karol Horvath. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Björn Norrlind's contributions to the field of injectable suspensions exemplify his commitment to innovation in pharmaceuticals. His patent and collaborative efforts highlight the importance of research and development in improving healthcare outcomes.